Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-22-054769
Filing Date
2022-05-02
Accepted
2022-05-02 17:08:20
Documents
14
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2214164d1_10ka.htm   iXBRL 10-K/A 367944
2 EXHIBIT 31.1 tm2214164d1_ex31-1.htm EX-31.1 4946
3 EXHIBIT 31.2 tm2214164d1_ex31-2.htm EX-31.2 4994
  Complete submission text file 0001104659-22-054769.txt   647004

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ganx-20211231.xsd EX-101.SCH 3057
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20211231_lab.xml EX-101.LAB 36509
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20211231_pre.xml EX-101.PRE 24014
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2214164d1_10ka_htm.xml XML 5873
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40237 | Film No.: 22883105
SIC: 2834 Pharmaceutical Preparations